PROSTATE CANCER (PC) The Prostate Cancer (PC) Program aims to advance scientific knowledge that will reduce the morbidity and mortality attributed to PC and lead to improvements in patients? quality of life. The PC Program has three primary aims: (1) Develop approaches for determining early stage PC risk, optimizing detection strategies, and deploying risk-based interventions; (2) Advance the molecular understanding of the androgen receptor signaling program to inform the rational design of therapeutic strategies for treating high-risk localized and metastatic PC; and (3) Evolve therapeutic approaches for the treatment of PCs directed toward inhibiting key oncogenic (intrinsic) drivers and modulating components of the tumor microenvironment. The PC Program has 42 members based at the University of Washington (UW) or Fred Hutch (FH), with clinical practice sites at the UW, Seattle Cancer Care Alliance (SCCA), and Veterans Administration (VA) Puget Sound Health Care System. Nine PC members have primary appointments at FH and 33 members at UW spanning 11 Departments and Divisions. Ten members joined this program since the last cycle. The current research portfolio of PC members is $11.6M (direct costs), of which $8.6M is peer-reviewed funding, including $2M from the NCI. A substantial component of the research funding is in the form of P50, P01, U54 and other collaborative grants. The Prostate Cancer program members published a total of 558 papers in the current grant period, of which 31% were intra-programmatic, 22% were inter-programmatic, and 56% had external co-authors. Eleven out of 12 Consortium Shared Resources were utilized by PC members in the course of their work. In addition to providing key shared resources, in particular Comparative Medicine, Genomics & Bioinformatics, and Research Pathology Shared Resources, the P30 CCSG supports this research program by providing administrative and logistical support for PC Program meetings; pilot funding for new research projects; and recruitment of new faculty.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-46
Application #
10125974
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-01
Project End
2024-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
46
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472
Bhatia, Shailender; Miller, Natalie J; Lu, Hailing et al. (2018) Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma. Clin Cancer Res :
Chozinski, Tyler J; Mao, Chenyi; Halpern, Aaron R et al. (2018) Volumetric, Nanoscale Optical Imaging of Mouse and Human Kidney via Expansion Microscopy. Sci Rep 8:10396
Holly, Mayumi K; Smith, Jason G (2018) Adenovirus infection of human enteroids reveals interferon sensitivity and preferential infection of goblet cells. J Virol :
Cheng, Heather H (2018) The resounding effect of DNA repair deficiency in prostate cancer. Urol Oncol 36:385-388
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
Eaton, Keith D; Romine, Perrin E; Goodman, Gary E et al. (2018) Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility. J Thorac Oncol 13:649-659

Showing the most recent 10 out of 1267 publications